| Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist SI Sayin, A Wahlström, J Felin, S Jäntti, HU Marschall, K Bamberg, ... Cell metabolism 17 (2), 225-235, 2013 | 2163 | 2013 |
| The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man C Gälman, T Lundåsen, A Kharitonenkov, HA Bina, M Eriksson, I Hafström, ... Cell metabolism 8 (2), 169-174, 2008 | 583 | 2008 |
| PPARα is a key regulator of hepatic FGF21 T Lundåsen, MC Hunt, LM Nilsson, S Sanyal, B Angelin, SEH Alexson, ... Biochemical and biophysical research communications 360 (2), 437-440, 2007 | 482 | 2007 |
| Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man T Lundåsen, C Gälman, B Angelin, M Rudling Journal of internal medicine 260 (6), 530-536, 2006 | 460 | 2006 |
| Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice S Alberti, G Schuster, P Parini, D Feltkamp, U Diczfalusy, M Rudling, ... The Journal of clinical investigation 107 (5), 565-573, 2001 | 456 | 2001 |
| Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders B Jones, EL Jones, SA Bonney, HN Patel, AR Mensenkamp, ... Nature genetics 34 (1), 29-31, 2003 | 442 | 2003 |
| Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice E Brakenhielm, R Cao, B Gao, B Angelin, B Cannon, P Parini, Y Cao Circulation research 94 (12), 1579-1588, 2004 | 418 | 2004 |
| Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice C Ohlsson, N Hellberg, P Parini, O Vidal, M Bohlooly, M Rudling, ... Biochemical and biophysical research communications 278 (3), 640-645, 2000 | 418 | 2000 |
| Influence of age on secretion of cholesterol and synthesis of bile acids by the liver K Einarsson, K Nilsell, B Leijd, B Angelin New England Journal of Medicine 313 (5), 277-282, 1985 | 392 | 1985 |
| Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia PW Ladenson, JD Kristensen, EC Ridgway, AG Olsson, B Carlsson, ... New England journal of medicine 362 (10), 906-916, 2010 | 375 | 2010 |
| Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. M Rudling, G Norstedt, H Olivecrona, E Reihnér, JA Gustafsson, ... Proceedings of the National Academy of Sciences 89 (15), 6983-6987, 1992 | 325 | 1992 |
| Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol E Reihnér, M Rudling, D Ståhlberg, L Berglund, S Ewerth, I Björkhem, ... New England Journal of Medicine 323 (4), 224-228, 1990 | 304 | 1990 |
| Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein AI metabolism, and fecal sterol excretion ME Brousseau, MR Diffenderfer, JS Millar, C Nartsupha, BF Asztalos, ... Arteriosclerosis, thrombosis, and vascular biology 25 (5), 1057-1064, 2005 | 302 | 2005 |
| Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver I Björkhem, T Miettinen, E Reihner, S Ewerth, B Angelin, K Einarsson Journal of lipid research 28 (10), 1137-1143, 1987 | 298 | 1987 |
| Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein AI: potential reverse cholesterol transport in humans M Eriksson, LA Carlson, TA Miettinen, B Angelin Circulation 100 (6), 594-598, 1999 | 295 | 1999 |
| Hepatic uptake of bile acids in man: fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum BO Angelin, I Björkhem, K Einarsson, S Ewerth The Journal of clinical investigation 70 (4), 724-731, 1982 | 272 | 1982 |
| ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver P Parini, M Davis, AT Lada, SK Erickson, TL Wright, U Gustafsson, ... Circulation 110 (14), 2017-2023, 2004 | 252 | 2004 |
| Apolipoprotein (a) and ischaemic heart disease in familial hypercholesterolaemia O Wiklund, SO Olofsson, G Fager, G Bondjers, B Angelin, M Erikson, ... The Lancet 335 (8702), 1360-1363, 1990 | 247 | 1990 |
| Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood C Gälman, I Arvidsson, B Angelin, M Rudling Journal of lipid research 44 (4), 859-866, 2003 | 241 | 2003 |
| Circulating fibroblast growth factors as metabolic regulators—a critical appraisal B Angelin, TE Larsson, M Rudling Cell metabolism 16 (6), 693-705, 2012 | 240 | 2012 |
